share_log

Maxim Group Maintains Buy on Sensus Healthcare, Raises Price Target to $10

Benzinga ·  May 10 11:09

Maxim Group analyst Anthony Vendetti maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $7 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment